0

Brain Protection in Schizophrenia, Mood and Cognitive Disorders

Erschienen am 21.05.2010, Auflage: 1/2010
213,99 €
(inkl. MwSt.)

Lieferbar innerhalb 1 - 2 Wochen

In den Warenkorb
Bibliografische Daten
ISBN/EAN: 9789048185528
Sprache: Englisch
Umfang: xv, 663 S.
Einband: gebundenes Buch

Beschreibung

InhaltsangabeForeword Michael S Ritsner Contributors Content Part I. Neuroprotective Strategies and Mechanisms The brain protection of patients with neuropsychiatric disorders. Ehud Susser, and Michael S. Ritsner Towards a new paradigm in neuroprotection and neuroplasticity. Dafin F. Muresanu What protects patients with schizophrenia from developing Alzheimer pathology? HansGert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner, Bernhard Bogerts Assessing neurodegeneration in vivo in schizophrenia using magnetic resonance. Jean Théberge Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. Sarah J. Bailey and Peter J. McCaffery Phosphatidylinositol 3kinase/glycogen synthase kinase and mitogenactivated protein kinase signalling cascades in neuronal cell survival: What the neurotrophins have taught us, and implications for neuropsychiatric disorders. Stephen D. Skaper Onecompoundmultitargets at amyloid b cascade offered by bis(7)Cognitin, a novel antiAlzheimer's dimmer. Wenming Li, Hongjun Fu, Moussa B.H. Youdim, Yuanping Pang, Yifan Han Common pathways to neurodegeneration and comorbid depression. Darcy Litteljohn, Emily N. Mangano, and Shawn Hayley Breakdown of the bloodbrain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. Hari S Sharma Oxidative stress and neurodegeneration: An inevitable consequence of aging? Implications for therapy. Roberto Rodrigues, David J. Bonda, George Perry, Rudy J. Castellani, Gemma Casadesus, Hyounggon Lee, HyunPil Lee, Xinglong Wang, Xiongwei Zhu, Robert B. Petersen, Mark A. Smith Carbon nanotubes as electrical interfaces with neurons. William Lee and Vladimir Parpura Part II. Neuroprotective Treatment and Neuromodulation Is a neuroprotective therapy suitable for schizophrenia patients? Michael S. Ritsner Recombinant human erythropoietin: Novel approach to neuroprotection and neuroregeneration in schizophrenia. Hannelore Ehrenreich, Martin Begemann, Claudia Bartels and Henning Krampe Neuroprotective agents in mood disorders: pathophysiological and therapeutic implications. Giacomo Salvadore, Husseini K Manji Neuroprotection in bipolar disorder. Chris Aiken New antiepileptic drugs in neuropsychiatric disorders basic and clinical pharmacology. Cecilie Johannessen Landmark and Svein I. Johannessen The neuroprotective efficacy of vitamins. Chanoch Miodownik, Vladimir Lerner Smoking and mental disorders: Focus on neuroprotection. Tsafrir Loebl Inhibitor of glycine transporter1 improves the functional outcome of schizophrenia. Christina Hui, and Guochuan Emil Tsai The role of oxytocin in neuropsychiatric disorders: Concepts and Mechanisms. Raz Levin, Shany Edelman, Idan Shalev, Richard P. Ebstein and Uriel HerescoLevy Neuromodulation for neuropsychiatric disorders: Novel techniques Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation. Russell J Andrews Index

Inhalt

Foreword Michael S Ritsner Contributors Content Part I. Neuroprotective Strategies and Mechanisms The brain protection of patients with neuropsychiatric disorders. Ehud Susser, and Michael S. Ritsner Towards a new paradigm in neuroprotection and neuroplasticity. Dafin F. Muresanu What protects patients with schizophrenia from developing Alzheimer pathology? Hans-Gert Bernstein, Theresia S. Ernst, Uwe Lendeckel, Henrik Dobrowolny, Johann Steiner, Bernhard Bogerts Assessing neurodegeneration in vivo in schizophrenia using magnetic resonance. Jean Theberge Vulnerability of the brain to neuropsychiatric disorders resulting from abnormal thyroid hormone or vitamin D homeostasis. Sarah J. Bailey and Peter J. McCaffery Phosphatidylinositol 3-kinase/glycogen synthase kinase and mitogen-activated protein kinase signalling cascades in neuronal cell survival: What the neurotrophins have taught us, and implications for neuropsychiatric disorders. Stephen D. Skaper One-compound-multi-targets at amyloid b cascade offered by bis(7)-Cognitin, a novel anti-Alzheimer¿s dimmer. Wenming Li, Hongjun Fu, Moussa B.H. Youdim, Yuanping Pang, Yifan Han Common pathways to neurodegeneration and co-morbid depression. Darcy Litteljohn, Emily N. Mangano, and Shawn Hayley Breakdown of the blood-brain barrier in stress alters cognitive dysfunction and induces brain pathology. New perspective for neuroprotective strategies. Hari S Sharma Oxidative stress and neurodegeneration: An inevitable consequence of aging? Implications for therapy. Roberto Rodrigues, David J. Bonda, George Perry, Rudy J. Castellani, Gemma Casadesus, Hyoung-gon Lee, Hyun-Pil Lee, Xinglong Wang, Xiongwei Zhu, Robert B. Petersen, Mark A. Smith Carbon nanotubes as electrical interfaces with neurons. William Lee and Vladimir Parpura Part II. Neuroprotective Treatment and Neuromodulation Is a neuroprotective therapy suitable for schizophrenia patients? Michael S. Ritsner Recombinant human erythropoietin: Novel approach to neuroprotection and neuroregeneration in schizophrenia. Hannelore Ehrenreich, Martin Begemann, Claudia Bartels and Henning Krampe Neuroprotective agents in mood disorders: pathophysiological and therapeutic implications. Giacomo Salvadore, Husseini K Manji Neuroprotection in bipolar disorder. Chris Aiken New antiepileptic drugs in neuropsychiatric disorders - basic and clinical pharmacology. Cecilie Johannessen Landmark and Svein I. Johannessen The neuroprotective efficacy of vitamins. Chanoch Miodownik, Vladimir Lerner Smoking and mental disorders: Focus on neuroprotection. Tsafrir Loebl Inhibitor of glycine transporter-1 improves the functional outcome of schizophrenia. Christina Hui, and Guochuan Emil Tsai The role of oxytocin in neuropsychiatric disorders: Concepts and Mechanisms. Raz Levin, Shany Edelman, Idan Shalev, Richard P. Ebstein and Uriel Heresco-Levy Neuromodulation for neuropsychiatric disorders: Novel techniques - Vagus Nerve Stimulation, Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, and Deep Brain Stimulation. Russell J Andrews Index

Unser Newsletter


Mit * gekennzeichnete Felder sind auszufüllen.

Unsere Datenschutzerklärung können Sie hier abrufen.